A new era for treatment of drug-resistant tuberculosis

Eur Respir J. 2018 Oct 4;52(4):1801350. doi: 10.1183/13993003.01350-2018. Print 2018 Oct.

Authors

Neel R Gandhi¹, James C M Brust², N Sarita Shah³

Affiliations

¹ Rollins School of Public Health and Emory School of Medicine, Emory University, Atlanta, GA, USA.
² Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
³ Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Antitubercular Agents / pharmacology*
Extensively Drug-Resistant Tuberculosis / drug therapy
Humans
Mycobacterium tuberculosis / drug effects*
Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

Antitubercular Agents

Grants and funding